Naturalendo Tech’s EstroG-100® Wins “Innovations in Women’s Health” at NutraIngredients Asia Awards 2026

Naturalendo Tech Co., Ltd., a leading developer of science-backed botanical ingredients for women’s health, announced that its proprietary botanical ingredient EstroG-100® has won the “Innovations in Women’s Health” Award at the NutraIngredients Asia Awards 2026, one of the Asia-Pacific region’s leading nutraceutical industry awards.
 

[Image by Naturalendo Tech Co., Ltd.]

In August, EstroG-100® was named a finalist in two categories at the NutraIngredients Asia Awards 2026: “Innovations in Women’s Health Award” and “Ingredient of the Year: Botanical.” Being shortlisted in both categories underscored EstroG-100®’s competitiveness as a botanical ingredient and its innovation in women’s health. At the final awards ceremony held in Bangkok, Thailand, on September 2, EstroG-100® was named the winner of the “Innovations in Women’s Health Award.”
 
Organized by NutraIngredients, a leading global publication covering the nutraceutical and health ingredients industries, the NutraIngredients Asia Awards recognize ingredients, products, and initiatives across the Asia-Pacific region that demonstrate outstanding innovation and strong scientific substantiation.
 
The 2026 awards received a record 256 entries, more than 30% higher than the previous year, marking the highest number of submissions in the history of the Asia edition. Innovations in Women’s Health was among the three categories that received the highest number of entries, highlighting the strong industry focus on women’s health. Against this highly competitive backdrop, EstroG-100® was recognized for its scientific substantiation and continued innovation, ultimately earning the top honor in the category.
 
EstroG-100® is a proprietary botanical composition developed from hot-water extracts of Cynanchum wilfordii, Phlomis umbrosa, and Angelica gigas. Developed as a non-hormonal solution for menopausal women, the ingredient is supported by an extensive body of scientific research, including six human clinical studies evaluating its efficacy and safety.
 

A Naturalendo Tech representative said, “Since 2010, EstroG-100® has continued to build a robust body of scientific evidence through ongoing research and development, alongside the expansion of its regulatory approvals in global markets.”
 
The representative continued, “One of EstroG-100®’s greatest competitive strengths is the continued expansion of its scientific research beyond overall menopausal symptom management. Research has increasingly explored areas including hot flashes, sleep, sexual health, serotonin-related pathways, and bone health, broadening both the scientific understanding of EstroG-100® and its potential applications.”
 
“This award represents another important global recognition of EstroG-100®’s continued innovation and scientific excellence,” the representative added. “Naturalendo Tech will continue to advance new research and innovation in women’s health while further strengthening the global competitiveness of EstroG-100®.”
  

정현식 기자